²é¿´: 801  |  »Ø¸´: 2
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßwfpzmd360073½«ÔùËÍÄú 30 ¸ö½ð±Ò
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

wfpzmd360073

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ÎÄÏ×ÇóÖú£¬¼±¼±¼±£¡£¡£¡£¡ ÒÑÓÐ1È˲ÎÓë

ÇóÖúһƪÁÙ´²Ñо¿ÎÄÕ£¬Â·¹ýµÄ´óÉñÇë°ï棬лл£¡£¡£¡£¡

Á´½Ó£ºhttps://pubmed.ncbi.nlm.nih.gov/38823410/

doi: 10.1016/S1470-2045(24)00159-1. Epub 2024 May 29

ÌâÄ¿£ºBL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
»Ø¸´´ËÂ¥
ÓÚϸ΢´¦¼ûÕæÖª
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tfang

ľ³æÖ®Íõ (ÎÄ̳¾«Ó¢)

ľ³æ008Ö®´óÀÁ³æ

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ͨ¹ýÍøÅÌ·ÖÏíµÄÎļþ£ºBL-B01D1, a first-in-class EGFR¨CHER3 bispecific antibody¨Cdrug conjugate, in patients with locally advanced or metastatic solid tumours a first-in-human, open-label, multicentre, phase 1 study._20251127_083531.pdf
Á´½Ó: https://pan.baidu.com/s/1Fjp97hdJLNbLM_NIE6nOHQ?pwd=bpib ÌáÈ¡Âë: bpib ¸´ÖÆÕâ¶ÎÄÚÈݺó´ò¿ª°Ù¶ÈÍøÅÌÊÖ»úApp£¬²Ù×÷¸ü·½±ãŶ
ͬ־ÃÇ£º±ð³´¹É£¬·çÏÕÌ«´óÁË£¬»¹ÊÇ×ö¶¹¸¯×ȫ£¡×öÓ²ÁËÊǶ¹¸¯¸É£¬×öÏ¡ÁËÊǶ¹¸¯ÄÔ£¬×ö±¡ÁËÊǶ¹¸¯Æ¤£¬×öûÁËÊǶ¹½¬£¬·Å³ôÁËÊdzô¶¹¸¯£¡ÎÈ׬²»¿÷ѽ£¡ºÎÀÖ¶ø²»Îª£¡
3Â¥2025-11-27 08:35:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 3 ¸ö»Ø´ð

zyqchem

ľ³æÖ®Íõ (ÎÄѧ̩¶·)

ÇëÒÆ²½ÎÄÏ×ÇóÖú°æ

[ ·¢×ÔÊÖ»ú°æ https://muchong.com/3g ]
2Â¥2025-11-26 12:01:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì½ò´óѧ085600 319·Ö ²ÄÁÏÓ뻯¹¤ ½ðÊô·½Ïò Çóµ÷¼Á +3 Çà¿Æ11 2026-03-02 3/150 2026-03-03 09:05 by houyaoxu
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶283Çóµ÷¼Á 5+6 £¬£¡£¿ 2026-03-02 8/400 2026-03-03 08:48 by ´óÑô0319
[¿¼²©] 26É격 +3 north£¬ 2026-02-28 3/150 2026-03-03 07:30 by 𥰲𥰲
[¿¼ÑÐ] 0857µ÷¼Á +6 Ò»ll°ë 2026-02-28 7/350 2026-03-03 04:28 by Áõ±ø
[¿¼ÑÐ] 0856µ÷¼Á +10 ÁõÃÎ΢ 2026-02-28 10/500 2026-03-02 23:42 by hcy618
[¿¼ÑÐ] 299Çóµ÷¼Á +4 kkcoco25 2026-03-02 7/350 2026-03-02 23:11 by kkcoco25
[¿¼ÑÐ] 267Çóµ÷¼Á +3 µöÓãÀÐas 2026-03-02 3/150 2026-03-02 22:11 by Elden123
[¿¼ÑÐ] 085600Çóµ÷¼Á +4 LRZZZZZZ 2026-03-02 5/250 2026-03-02 20:33 by ÔÆÆìyunqi
[¿¼ÑÐ] 261Çóµ÷¼Á +3 ½lh 2026-03-01 3/150 2026-03-02 19:32 by zhukairuo
[¿¼ÑÐ] 0856»¯¹¤×¨Ë¶Çóµ÷¼Á +15 ¶­boxing 2026-03-01 15/750 2026-03-02 15:06 by »Î»Î²»Ðí»Î
[¿¼ÑÐ] 291 Çóµ÷¼Á +3 »¯¹¤2026½ì±ÏÒµÉ 2026-03-02 3/150 2026-03-02 12:55 by houyaoxu
[¿¼ÑÐ] 292Çóµ÷¼Á +7 yhk_819 2026-02-28 7/350 2026-03-02 12:43 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 284Çóµ÷¼Á +10 ÌìÏÂŸß 2026-02-28 11/550 2026-03-02 11:03 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 264Çóµ÷¼Á +4 °ÍÀ­°ÍÀ­¸ù556 2026-02-28 4/200 2026-03-02 10:48 by yuchj
[¿¼ÑÐ] 279Çóµ÷¼Á +3 dua1 2026-03-01 4/200 2026-03-02 00:23 by ´óÁ³µ°×Ó
[¿¼ÑÐ] »¯¹¤299·ÖÇóµ÷¼Á Ò»Ö¾Ô¸985Âä°ñ +5 ÎûÎû(*^¦Ø^*) 2026-03-01 5/250 2026-03-01 19:47 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 328Çóµ÷¼Á +3 aaadim 2026-03-01 5/250 2026-03-01 17:29 by njzyff
[»ù½ðÉêÇë] ¸Õ¼Óã¬Ã»ÓÐÆÚ¿¯ºÅ£¬µ«ÊÇÔÚÏ߿ɿ´µÄÂÛÎÄ¿ÉÒÔ·ÅΪ´ú±í×÷Âð 10+3 arang1 2026-03-01 3/150 2026-03-01 16:43 by babero
[¿¼ÑÐ] 307Çóµ÷¼Á +4 73372112 2026-02-28 6/300 2026-03-01 00:04 by ll247
[˶²©¼ÒÔ°] ¡¾²©Ê¿ÕÐÉú¡¿Ì«Ô­Àí¹¤´óѧ2026»¯¹¤²©Ê¿ +4 N1ce_try 2026-02-24 8/400 2026-02-26 08:40 by N1ce_try
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û